Dr. Ravi Kumar

After two decades in medicine, I started questioning everything.

Dr. Ravi Kumar is a board-certified neurosurgeon who left the operating room to explore the questions that matter most about your health.

Listen to the Podcast

Every week, I cut through the noise of health headlines and marketing claims to bring you what the research actually says. No dogma, no agenda, just an honest look at the science that shapes how you live, heal, and thrive.

Dr. Ravi Kumar
About Dr. Kumar

A neurosurgeon who started questioning everything

Dr. Ravi Kumar is a board-certified neurosurgeon and assistant professor of neurosurgery at the University of North Carolina. After years in the operating room, a transformative sabbatical in India changed how he saw medicine forever.

Now, through The Dr. Kumar Discovery, he explores the intersection of modern science, traditional wisdom, and the questions most doctors never think to ask.

Read the full story

Latest Health News

See all news
Older couple walking briskly together on a sunlit park path lined with green trees in warm golden afternoon light
Cardiovascular News

NT-proBNP that returns to normal carries near-normal risk

In 8,454 adults aged 70 and older, newly elevated heart stress raised 8-year cardiovascular risk by 7.4 percentage points, but people whose level came back down looked like those who never had it.

A gloved researcher holding a small clear culture dish of living cells under warm laboratory light, with stainless steel surgical instruments arranged on a tray softly out of focus behind
Cardiovascular News

Lab-grown heart cells pass first randomized safety test

A 20-patient randomized trial in Nature Medicine found no tumors and no sustained ventricular tachycardia after injecting lab-grown human heart muscle cells during bypass surgery, but every patient who got the cells developed an abnormal rhythm within a month.

Gloved hands arranging small amber medication bottles on a bright clinic counter in soft natural daylight
Metabolic News

Chemo-free combo stalled metastatic breast cancer 25 months

In the 29-patient ASPIRE trial, anastrozole, palbociclib, trastuzumab and pertuzumab held advanced breast cancer in check for a median of nearly 25 months without any chemotherapy, though 62 percent of patients still had a severe side effect.

What Listeners Are Saying

★★★★★

"So glad I found this podcast. Dr. Kumar doesn't want you to just mask symptoms, he wants you to understand root causes and help you truly heal. He is the best of both worlds - he shares a wealth of modern medical knowledge, but also empowers the listeners to take personal responsibility for their health."

cngggggggggg
★★★★★

"I love this podcast! It's smart and covers the science in very accessible ways. After each episode I feel empowered to make some changes in my life. Thanks, Dr. Kumar!"

Dr Kumar Review
★★★★★

"Dr Kumar's podcasts have been such a great find! As an OR nurse I have worked with neurosurgeons for years. I found the podcasts to be informative, easy to follow and just the right length."

NRRN66

Reviews from Apple Podcasts